Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

A randomized, parallel-group open-label trial of ENDS users switching from flavors of potentially high-toxicity profile to flavors of potentially low-toxicity profile (CRoFT_3.2)

Principal Investigator: Goniewicz, Maciej L

(PBTC-060) A Pilot Study of Safety, Tolerability, and Immunological Effects of SurVaxM in Pediatric Patients with Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Principal Investigator: Twist, Clare J

A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects with Light Chain (AL) Amyloidosis

Principal Investigator: Hillengass, Jens

Does Prophylactic Antibiotic Decrease the Rate of Urinary Tract Infection after Robot Assisted Radical Cystectomy

Principal Investigator: Guru, Khurshid

Pharmacokinetics, subjective effects, and abuse liability of nicotine salt-based vaping products with tobacco or unflavored e-liquids [SALTVAPE Study]

Principal Investigator: Quisenberry, Amanda J

(APEC1621SC) NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE) SCREENING PROTOCOL

Principal Investigator: Twist, Clare J

METFORMIN FOR CHEMOPREVENTION OF LUNG CANCER IN HIGH-RISK OBESE INDIVIDUALS

Principal Investigator: Yendamuri, Sai

A FIRST-IN-HUMAN PHASE 1/2 OPEN-LABEL STUDY OF INTRAVENOUS ST 067, SUBCUTANEOUS ST-067 WITH OR WITHOUT OBINUTUZUMAB PRE TREATMENT, AND ST-067 IN COMBINATION WITH PEMBROLIZUMAB IN SUBJECTS WITH ADVANCED SOLID MALIGNANCIES

Principal Investigator: Puzanov, Igor

Photoacoustic Imaging of Human Breast

Principal Investigator: Bonaccio, Ermelinda

A Phase I/II Basket Trial of the EGF Vaccine CIMAvax in Combination with the Anti-PD1 Therapy in Patients with Advanced NSCLC or Squamous Head and Neck Cancer

Principal Investigator: Jain, Prantesh

UPCC 04219: Phase 2 Study of Capecitabine-Temozolomide(CapTem) with yttrium-90 Radioembolization in the Treatment of Patients with Unresectable Metastatic Grade 2 Neuroendocrine Tumors

Principal Investigator: Iyer, Renuka V

NRG-GU009: PARALLEL PHASE III RANDOMIZED TRIALS FOR HIGH RISK PROSTATE CANCER EVALUATING DE-INTENSIFICATION FOR LOWER GENOMIC RISK AND INTENSIFICATION OF CONCURRENT THERAPY FOR HIGHER GENOMIC RISK WITH RADIATION (PREDICT-RT*)
*Prostate RNA Expression…

Principal Investigator: Kuettel, Michael R

A Phase Ib/2 study of IMGN632 as Monotherapy or Combination with Venetoclax and/or Azacitidine for Patients with CD123-Positve Acute Myeloid Leukemia

Principal Investigator: Wang, Eunice S

(AAML18P1) Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)

Principal Investigator: Twist, Clare J

BMT CTN 1904 Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for the Treatment of Bone Marrow Failure Diseases

Principal Investigator: Buxbaum, Nataliya P

A Phase 2 Randomized Study with a non-Randomized Cohort: Assessing Single-fraction SBRT versus STandard PalliativE Radiation In Patients with Metastatic Disease (ASTEROID)

Principal Investigator: Singh, Anurag K

Influence of Yoga on Cancer-Related Stress in Cancer Survivors

Principal Investigator: Glaser, Kathryn M

Investigating the Correlation Between the Brain and Pelvic Floor Muscle Activity of
Patients who had or are Undergoing Robot-Assisted Radical Prostatectomy

Principal Investigator: Guru, Khurshid

A Feasibility and Toxicity Analysis of Single Fraction Stereotactic Body Radiation Therapy for Post-Operative Non-Small Cell Lung Cancer

Principal Investigator: Singh, Anurag K

Treatment Free Remission After Combination Therapy with Ruxolitinib Plus Tyrosine Kinase Inhibitors in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Principal Investigator: Thompson, J

Nutrition and Exercise Interventions to Reduce Androgen Deprivation Therapy-induced Obese Frailty in Survivors of Advanced Prostate Cancer

Principal Investigator: Chatta, Gurkamal S

(S1706) A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer

Principal Investigator: Fung-Kee-Fung, Simon

A Phase I Study of Safety and Immunogenicity of Survivin Long Peptide Vaccine (SurVaxM) in Patients with Metastatic Neuroendocrine Tumors (NETs)

Principal Investigator: Iyer, Renuka V

Managed Access Program (MAP) Cohort Treatment Plan CCTL019B2003I to provide access for patients with out of specification leukapheresis product and/or out of specification manufactured tisagenlecleucel (CTL019; Kymriah®)

Principal Investigator: Ross, Maureen

A Phase II Trial of Lamivudine in Combination with Chemoimmunotherapy in Patients with Extensive Stage SCLC

Principal Investigator: Dy, Grace K